Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The design of the study includes 3 groups for women with premenstrual syndrome, 1low dose acupuncture in the low-dose group, 2 high dose acupuncture in the high-dose group, and 3 the drug group (contraceptives) . Serum marker change of PGE2, CA125, E2, and progesterone in enrolled patients will be measured before and after treatment, along with VAS and MDQ questionnaires. The treatment efficacy of different groups and the relationship between PMS and patients TCM syndrome pattern will also be recorded and estimated.
Premenstrual syndrome (PMS) is the sum of a group of symptoms (including physical and psychological symptoms) that occurs during the luteal phase of the menstrual cycle. Women who have such symptoms have been estimated as high as 75%; of which 3% to 8% are severe symptoms, called premenstrual dysphoric disorder (premenstrualdysphoric syndrome, PMDD). The two groups are very similar. PMS is mostly for physical discomfort, while PMDD is for emotional problems, affecting women's sleep seriously.
Regarding the treatment of premenstrual syndrome (PMS), western medicine adopt oral contraceptive pills (OCP) as the first-line medication. However, the common side effects of OCP, such as headache, dizziness, nausea, vomiting, depression, breast pain and so on are also troublesome, In recent years, some women also use acupuncture as an adjunctive replacement therapy because of its safety and fewer side effects. Nevertheless, the factors affecting treatment effect of acupuncture and moxibustion. such as the selection of acupoint s ( of which meridians) or number(dose) of acupuncture ,etc., maight affect the efficacy, yet the relevant research on this issue is not enough. In traditional Chinese medicine theory, acupuncture and moxibustion regulate the energy of the meridians and adjust blood and qi, which in turn help the balance of yin and yang. Female menstrual cycle is a process of conversion between yin and yang in TCM theory. While in western medicine, it is regulated by the endocrine system.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Conventional Gynecologic Treatment group | Active Comparator | Taking NSAIDs or oral contraceptives.NSAIDs include Ibuprofen, Naproxen, Diclofenac, and Piroxicam. Oral contraceptives include Yasmin. |
|
| Low dose acupuncture group | Experimental | Acupuncture has fewer acupuncture points. |
|
| High dose acupuncture group | Experimental | Acupuncture has more acupuncture points. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| NSAIDs or oral contraceptives treatment | Drug | Taking NSAIDs or oral contraceptives.NSAIDs include Ibuprofen, Naproxen, Diclofenac, and Piroxicam. Oral contraceptives include Yasmin. |
| Measure | Description | Time Frame |
|---|---|---|
| Wang Qi Chinese Medicine Questionnaire | This questionnaire is used to survey TCM constitutions. Evaluate body constitution of | Change from Baseline TCM constitutions at 4 cycles (each cycle is 30 days). |
| Measure | Description | Time Frame |
|---|---|---|
| Visual analogue scale(VAS) score | VAS is used to assess the extent of menstrual pain. | Change from Baseline VAS score at 4 cycles (each cycle is 30 days). |
| Blood test estrogen | Change from Baseline blood test at 4 cycles (each cycle is 30 days). |
Not provided
Inclusion Criteria:
1.15 to 49 years 2.with a history of regular menstrual cycles (28days±7 days) 3.Symptoms:breast pain、dizziness、bloating、cramps、nausea、vomiting、 diarrhea、headache、 fatigue,etc
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Tsai-Ju Chien | Taipei City Hospital | Principal Investigator |
| Yi-Shuo Huang | Taipei City Hospital | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Taipei City H | Taipei | Taiwan |
This study will have a continuous plan.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D011293 | Premenstrual Syndrome |
| ID | Term |
|---|---|
| D008599 | Menstruation Disturbances |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D000894 | Anti-Inflammatory Agents, Non-Steroidal |
| D009288 | Naproxen |
| D004008 | Diclofenac |
| D015670 | Acupuncture Therapy |
| ID | Term |
|---|---|
| D018712 | Analgesics, Non-Narcotic |
| D000700 | Analgesics |
| D018689 | Sensory System Agents |
| D018373 | Peripheral Nervous System Agents |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Low dose acupuncture | Device | Six acupoints: Three Yin Intersection( SP6)、Grandfather Grandson(SP4)、 Sea of Blood(SP10) 、Sea of Qi(RN6)、Origin Pass(RN4) 、Inner Pass(PC6) |
|
| High dose acupuncture | Device | Twelve acupoints: Three Yin Intersection( SP6)、Grandfather Grandson(SP4)、 Sea of Blood(SP10) 、Sea of Qi(RN6)、Origin Pass(RN4) 、Middle Extremity(RN3)、Inner |
|
| Blood test progesterone | Change from Baseline blood test at 4 cycles (each cycle is 30 days). |
| Blood test prostaglandin | Change from Baseline blood test at 4 cycles (each cycle is 30 days). |
| Menstrual Distress Questionnaire(MDQ) | Contain: Pain;Concentration;Behavioral Change;Autonomic Reactions;Water Retention;Negative Affect | Change from Baseline Menstrual Distress Questionnaire at 4 cycles (each cycle is 30 days). |
| D045505 | Physiological Effects of Drugs |
| D020228 | Pharmacologic Actions |
| D020164 | Chemical Actions and Uses |
| D000893 | Anti-Inflammatory Agents |
| D045506 | Therapeutic Uses |
| D018501 | Antirheumatic Agents |
| D009280 | Naphthaleneacetic Acids |
| D009281 | Naphthalenes |
| D011084 | Polycyclic Aromatic Hydrocarbons |
| D006841 | Hydrocarbons, Aromatic |
| D006844 | Hydrocarbons, Cyclic |
| D006838 | Hydrocarbons |
| D009930 | Organic Chemicals |
| D011083 | Polycyclic Compounds |
| D010648 | Phenylacetates |
| D000146 | Acids, Carbocyclic |
| D002264 | Carboxylic Acids |
| D000529 | Complementary Therapies |
| D013812 | Therapeutics |